Atlas Trials

A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients

Clinical trial NCT06249919 · RECRUITING

Trial details

NCT number
NCT06249919
Sponsor
Neuracle Science Co., LTD.
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Seneorineural DeafnessSudden Sensorineural Hearing Loss
Start date
2024-01-19
Primary completion
2026-05-31
Enrollment
138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.